A detailed history of Lpl Financial LLC transactions in Glaukos Corp stock. As of the latest transaction made, Lpl Financial LLC holds 13,417 shares of GKOS stock, worth $2.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,417
Previous 12,587 6.59%
Holding current value
$2.02 Million
Previous $1.49 Million 17.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$113.62 - $135.39 $94,304 - $112,373
830 Added 6.59%
13,417 $1.75 Million
Q2 2024

Aug 07, 2024

BUY
$89.48 - $118.35 $21,027 - $27,812
235 Added 1.9%
12,587 $1.49 Million
Q1 2024

May 10, 2024

SELL
$76.4 - $96.33 $256,092 - $322,898
-3,352 Reduced 21.34%
12,352 $1.16 Million
Q4 2023

Feb 14, 2024

BUY
$59.53 - $85.11 $1,309 - $1,872
22 Added 0.14%
15,704 $1.25 Million
Q3 2023

Nov 13, 2023

SELL
$69.23 - $79.09 $67,776 - $77,429
-979 Reduced 5.88%
15,682 $1.18 Million
Q2 2023

Jul 31, 2023

BUY
$45.44 - $71.21 $137,092 - $214,840
3,017 Added 22.11%
16,661 $1.19 Million
Q1 2023

May 10, 2023

BUY
$43.88 - $52.48 $55,683 - $66,597
1,269 Added 10.25%
13,644 $683,000
Q4 2022

Feb 07, 2023

SELL
$40.82 - $57.75 $1,224 - $1,732
-30 Reduced 0.24%
12,375 $540,000
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $97,661 - $121,951
2,085 Added 20.2%
12,405 $660,000
Q2 2022

Aug 12, 2022

BUY
$34.86 - $63.77 $84,849 - $155,216
2,434 Added 30.86%
10,320 $469,000
Q1 2022

May 16, 2022

BUY
$44.33 - $57.82 $72,878 - $95,056
1,644 Added 26.34%
7,886 $456,000
Q4 2021

Feb 14, 2022

BUY
$40.27 - $56.99 $251,365 - $355,731
6,242 New
6,242 $277,000
Q3 2021

Nov 15, 2021

SELL
$47.43 - $84.23 $137,309 - $243,845
-2,895 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$73.06 - $97.7 $211,508 - $282,841
2,895 New
2,895 $246,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.